NRG1 and heart disorder: Research has also found that  recombinant growth factor NRG1 (rNRG1)  can induce the proliferation of cardiomyocytes in infants under 6 months of age with heart disease [176], indicating that the NRG1 signaling pathway is conserved and may serve as an effective therapeutic strategy for pediatric heart disease.